Pierre Fabre Medicament - Supercritical Fluids Division - Bioavailability Enhancement – Improvement of Solubility – Taste-Masking – Particle Design

These equipment allow us to manufacture batches from a few kilograms up to 30 Kg, this batch size is sufficient to cover Phase I, II, III clinical studies needs.

• 
  Cytotoxic solids handling zone for high potency drugs.
• 
  A CO2 pump (500 Kg/h).
• 
  These equipment allow us to manufacture batches from a few kilograms up to 30...
• 
  The annual production capacity is around 20 tons.
• 
  Pierre Fabre Medicament has been ISO 14001 certified since 1998 and awarded...

Back to Company Details